ArticleArchives of toxicology2026
Depleted uranium exposure induced ferroptosis in renal cells via the ETHE1/P38-MAPK pathway.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review).International journal of molecular medicine · 2026Review
- M2 Macrophage-Derived Exosomes Ameliorate BPD by Inhibiting Ferroptosis via Suppression of the ZAKα-p38 Signaling Pathway.Antioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study investigated the role of ferroptosis in acute depleted uranium (DU)-induced nephrotoxicity. Using Sprague-Dawley rats and HK-2 cells to establish models of acute DU exposure (rats: 10 mg/kg; cells: 500 μM for 24 h), we found that DU exposure caused mitochondrial dysfunction, lipid peroxidation, and iron accumulation, all hallmarks of ferroptosis, which were inhibited by ferrostatin-1 (Fer-1). We identified mitochondrial ethylmalonic encephalopathy 1 (ETHE1) as a key DU target. ETHE1 downregulation exacerbated DU-induced reactive oxygen species (ROS), ferrous ions (Fe
Indexed as
Identifiers
41201583What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.